Morgan Stanley: IFF’s third-quarter growth beats expectations, but fourth-quarter profit guidance is soft
Fragrance and Taste drove comparable sales growth in the third quarter, but weakness in Health & Biosciences, higher expenses and a shift to negative cash flow point to cautious fourth-quarter earnings expectations behind the raised full-year guidance.